Diagnostics

Company launches 10 new point-of-care rapid test products

Published in Blood Weekly, September 16th, 2004

DiaSys Corp. (DYX), a global healthcare products company, announced the introduction of 10 new point-of-care rapid test products for worldwide distribution.

These new products consist of four cardiac markers, three cancer markers, two infectious disease tests, and a thyroid test.

These new products will be listed on the company's website and sold through DiaSys Corp.'s worldwide distribution network. The four cardiac markers are Troponin I, CK-MB, Myoglobin, and CRP; the three cancer markers are Id1, HMGA2, and Alpha Fetoprotein; the two infectious disease tests are a Malaria Combo Test and Dengue IgG and IgM; and the thyroid test is a Neonatal TSH....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-09-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry